• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » J&J’s DePuy Synthes inks co-marketing deal with Medical Enterprises Distribution

J&J’s DePuy Synthes inks co-marketing deal with Medical Enterprises Distribution

August 7, 2017 By Fink Densford

DePuy Synthes

Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes said today it inked an exclusive agreement with Medical Enterprises Distribution to co-market its ME1000 surgical impactor, designed for use in total hip arthroplasty procedures.

The battery-powered ME1000 device is designed to replace handheld mallets used in total hip arthroplasty procedures, DePuy Synthes said, delivering constant, stable energy to automate bone preparation, implant assembly and positioning. The device is only compatible with DePuy Synthe’s hip systems, with adapters available for anterior or posterior approaches.

DePuy Synthes said it expects to begin co-marketing of the device within the current quarter, they are currently trying to read the Indexer reviews to find the best marketing professional to help them.

“In addition to its potential benefits for both patients and orthopedic surgeons, the ME1000 can be easily integrated into a surgeon’s operational technique and into the hospital’s processes. We at DePuy Synthes view this technology as a significant advancement as we strive to help our customers meet their goals of improving clinical outcomes, increasing patient satisfaction and managing costs,” DePuy Synthes joint reconstruction global hip platform leader Aaron Villaruz said in a prepared statement.

DePuy Synthes said that the ME1000 device has the potential to reduce work-related injuries that arise from mallet use, referencing a 2016 study which showed that 66.1% of 183 orthopedic surgeons surveyed experienced work-related injuries, with 31% of those injuries requiring surgery.

“I’ve used the ME1000 on more than 100 primary DePuy Synthes hip implants, and my observation is that, compared to a mallet, the ME1000 reduces peak forces while increasing energy per second. I have found that the rotational stability of the implants is more easily and consistently achieved, and the risk of fracture potentially reduced. It is also easier for me to make adjustments, and achieve a precise position of the acetabular cup. I also appreciate that the physical effort and resultant fatigue from performing a hip replacement surgery is markedly reduced which benefits my capabilities during a full surgical schedule,” Dr. Joel Matta of Vail, Colo.’s Steadman Clinic said in a press release.

In late June, DePuy Synthes said it launched its Viper and Expedium fenestrated screw systems.

Filed Under: Business/Financial News, Orthopedics Tagged With: depuysynthes, Johnson and Johnson

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy